Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

BACKGROUND: Increased sexual risk behaviour in participants enrolled in HIV prevention trials has been a concern. The HVTN 503/Phambili study, a phase 2B study of the Merck Ad-5 multiclade HIV vaccine in South Africa, suspended enrollment and vaccinations following the results of the Step study. Par...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gray, GE, Metch, B, Churchyard, G, Mlisana, K, Nchabeleng, M, Allen, M, Moodie, Z, Kublin, J, Bekker, L-G
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3942784/
https://ncbi.nlm.nih.gov/pubmed/23370155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.01.031
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky